Table 4.
Covariates | Relative risk (95 % CI) | P |
---|---|---|
Age, year | 0.97 (0.94–1.01) | 0.12 |
Women | 0.81 (0.21–3.05) | 0.75 |
SLE duration, year | 0.98 (0.93–1.04) | 0.47 |
RNA vaccine (vs inactivated vaccine) | 0.76 (0.34–1.69) | 0.50 |
Active SLE serology before vaccination | 2.63 (1.05–6.62) | 0.04 |
Use of prednisolone at time of vaccination | 1.95 (0.91–4.19) | 0.09 |
Anti-Sm | 1.67 (0.64–4.39) | 0.30 |
Anti-nRNP | 1.31 (0.52–3.33) | 0.57 |
History of arthritis | 2.71 (1.05–7.00) | 0.04 |
History of discoid skin lesions | 4.73 (1.90–11.8) | 0.001 |
*CI = confidence interval; SLE = systemic lupus erythematosus.